Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

What is Cancer?02:12

What is Cancer?

12.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
12.6K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.4K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.4K
Cancer02:18

Cancer

51.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Tumor Progression02:07

Tumor Progression

6.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Cancer Prevention02:59

Cancer Prevention

7.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

508
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
508

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Diagnosis-independent contribution of low-grade inflammation to cortical atrophy across psychiatric disorders.

Brain, behavior, and immunity·2026
Same author

Challenges and strategies for delivering effective breast cancer care in conflict zones.

Communications medicine·2026
Same author

Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identification.

Virchows Archiv : an international journal of pathology·2026
Same author

Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer.

NPJ breast cancer·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Nov 10, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K

乳がん

Sibylle Loibl1, Philip Poortmans2, Monica Morrow3

  • 1German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany.

Lancet (London, England)
|April 4, 2021
PubMed
まとめ
この要約は機械生成です。

乳がんの治療は分子および免疫マーカーによって進化し,パーソナライズされたネオアジュバント療法と低濃度放射線療法が可能になりました. 先進的な標的治療薬と免疫療法は 転移性疾患に合わせた選択肢を提供しています

さらに関連する動画

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.5K
Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

80.3K

関連する実験動画

Last Updated: Nov 10, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.5K
Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

80.3K

科学分野:

  • 腫瘍学
  • 分子生物学
  • 免疫学

背景:

  • 乳がんは世界の主要ながんであり, 分子特性により理解が進化しています
  • 主なマーカーには免疫ヒストキミカル (ER,PR,HER2,Ki-67),ゲノム (BRCA1/ 2,PIK3CA),免疫マーカー (TIL,PD- L1) が含まれる.

研究 の 目的:

  • 乳がんの診断と治療の進歩を強調する
  • 分子プロファイルの パーソナライズド医療への移行を強調します

主な方法:

  • 複数のバイオマーカーの組み合わせを含む現在の診断アルゴリズムのレビュー.
  • 標的薬および免疫療法を含む新補助薬および転移性治療戦略の分析

主要な成果:

  • ネオアジュバント併用療法 (HER2陽性,トリプルネガティブ) は標準的なもので,外科的緩和および治療後の戦略を指針としています.
  • 内分泌療法 (5~10年) と化学療法が,ER陽性腫瘍のリスクに基づいて用いられる.
  • 転移治療には,CDK4/ 6,PI3K,PARP阻害剤,および腫瘍プロファイルに合わせた抗PD- L1免疫療法が含まれています.

結論:

  • 乳がんの治療は バイオマーカーの進歩により 複雑化しています
  • 個別化された治療戦略が標準になりつつあります 新補助医療から転移性疾患の管理までです